These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7975511

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR, UK Haemophilia Centre Doctors.
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A summary of the world-wide clinical investigations of recombinant factor VIII.
    Schwartz RS, Rousell RH.
    Semin Hematol; 1991 Apr; 28(2 Suppl 1):53-4. PubMed ID: 1908130
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Immune tolerance to Factor VIII: the international registry data.
    Mariani G, Hilgartner M, Thompson AR, Tusell J, Manco-Johnson M, Ghirardini A, Bellocco R, Brackmann HH.
    Adv Exp Med Biol; 1995 Apr; 386():201-8. PubMed ID: 8851029
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical efficacy of recombinant factor VIII. The rFactor VIII Clinical Trial Group.
    Arkin S, Rose E, Forster A, Aledort LM.
    Semin Hematol; 1991 Apr; 28(2 Suppl 1):47-51. PubMed ID: 1908129
    [Abstract] [Full Text] [Related]

  • 31. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul 15; 153(2):147-57. PubMed ID: 7600466
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Immunogenicity of factor VIII concentrates in patients with hemophilia: a randomized clinical trial is warranted.
    Gringeri A, Mannucci PM.
    Blood; 2007 Oct 15; 110(8):3084; author reply 3085. PubMed ID: 17916754
    [No Abstract] [Full Text] [Related]

  • 36. The pharmacokinetics of recombinant factor VIII. The rFactor VIII Clinical Trial Group.
    Harrison JF, Bloom AL, Abildgaard CF.
    Semin Hematol; 1991 Apr 15; 28(2 Suppl 1):29-35; discussion 36. PubMed ID: 1908124
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Physiopathology and therapy of hemophilia and von Willebrand's disease].
    Fukui H.
    Nihon Naika Gakkai Zasshi; 1991 Jun 10; 80(6):866-74. PubMed ID: 1919201
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.